| J3111 | Injection, romosozumab-aqqg, 1 mg | 23,730 | $10 | $189.8K |
| J0897 | Injection, denosumab, 1 mg | 6,360 | $20 | $114.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,190 | $90 | $107.4K |
| 77080 | The provider performs an imaging procedure, called dual–energy X–ray absorptiometry (DXA), of one or more bony areas on the trunk to determine the bone mineral density (BMD) and whether the patient… | 810 | $40 | $29.3K |
| 95251 | A provider analyzes and interprets data from a patient’s continuous glucose monitor (CGM) and writes a report based on interpretation. This code represents the professional component of the service… | 490 | $30 | $12.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 220 | $60 | $12.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 70 | $140 | $9.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 80 | $120 | $9.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $60 | $9.2K |
| 95250 | In this procedure, interstitial glucose levels are measured at regular intervals via subcutaneously implanted sensors provided by physician or other qualified health care professional's office for a… | 80 | $100 | $8K |